Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Abstracts In Press
    • Archives
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Abstracts In Press
    • Archives
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM on Bluesky
  • JABFM On Facebook
  • JABFM On Twitter
  • JABFM On YouTube
Research ArticleOriginal Research

Impact of Pharmacist Previsit Input to Providers on Chronic Opioid Prescribing Safety

Nicholas Cox, Casey R. Tak, Susan E. Cochella, Eric Leishman and Karen Gunning
The Journal of the American Board of Family Medicine January 2018, 31 (1) 105-112; DOI: https://doi.org/10.3122/jabfm.2018.01.170210
Nicholas Cox
From the Department of Pharmacy Services (NC, KG) and Department of Family and Preventive Medicine (SEC), University of Utah Health, Salt Lake City; the Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City (NC, CRT, EL, KG); and the Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City (SEC, KG).
PharmD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Casey R. Tak
From the Department of Pharmacy Services (NC, KG) and Department of Family and Preventive Medicine (SEC), University of Utah Health, Salt Lake City; the Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City (NC, CRT, EL, KG); and the Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City (SEC, KG).
BA, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan E. Cochella
From the Department of Pharmacy Services (NC, KG) and Department of Family and Preventive Medicine (SEC), University of Utah Health, Salt Lake City; the Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City (NC, CRT, EL, KG); and the Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City (SEC, KG).
MD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric Leishman
From the Department of Pharmacy Services (NC, KG) and Department of Family and Preventive Medicine (SEC), University of Utah Health, Salt Lake City; the Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City (NC, CRT, EL, KG); and the Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City (SEC, KG).
PharmD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karen Gunning
From the Department of Pharmacy Services (NC, KG) and Department of Family and Preventive Medicine (SEC), University of Utah Health, Salt Lake City; the Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City (NC, CRT, EL, KG); and the Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City (SEC, KG).
PharmD, BCPS, BCACP, FCCP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

References

  1. 1.↵
    1. Paulozzi LJ,
    2. Mack KA,
    3. Hockenberry JM
    . Vital signs: variation among states in prescribing of opioid pain relievers and benzodiazepines—United States, 2012. MMWR Morb Mortal Wkly Rep 2014;63:563–8.
    OpenUrlPubMed
  2. 2.↵
    Centers for Disease Control and Prevention. Understanding the epidemic. Available from: http://www.cdc.gov/drugoverdose/epidemic/index.html. Last updated and reviewed August 20, 2017. Accessed July 29, 2016.
  3. 3.↵
    Centers for Disease Control and Prevention. Opioid overdose. Available from: http://www.cdc.gov/drugoverdose/index.html. Last updated and reviewed October 23, 2017. Accessed July 29, 2016.
  4. 4.↵
    Library of Congress. S.524 - Comprehensive Addiction and Recovery Act of 2016, Pub. L. No. 114–198, 114th Congress. Available from: https://www.congress.gov/bill/114th-congress/senate-bill/524/text. Published July 22, 2016. Accessed July 22, 2016.
  5. 5.↵
    1. Dowell D,
    2. Haegerich TM,
    3. Chou R
    . CDC guideline for prescribing opioids for chronic pain - United States, 2016. MMWR Recomm Rep 2016;65:1–49.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Levy B,
    2. Paulozzi L,
    3. Mack KA,
    4. Jones CM
    . Trends in opioid analgesic-prescribing rates by specialty, U.S., 2007–2012. Am J Prev Med 2015;49:409–13.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Breuer B,
    2. Cruciani R,
    3. Portenoy RK
    . Pain management by primary care physicians, pain physicians, chiropractors, and acupuncturists: a national survey. South Med J 2010;103:738–47.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Leverence RR,
    2. Williams RL,
    3. Potter M,
    4. et al
    . Chronic non-cancer pain: a siren for primary care—a report from the Primary Care Multiethnic Network (PRIME Net). J Am Board Fam Med 2011;24:551–61.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Anderson D,
    2. Wang S,
    3. Zlateva I
    . Comprehensive assessment of chronic pain management in primary care: a first phase of a quality improvement initiative at a multisite community health center. Qual Prim Care 2012;20:421–33.
    OpenUrlPubMed
  10. 10.↵
    1. Green CR,
    2. Wheeler JR,
    3. Marchant B,
    4. LaPorte F,
    5. Guerrero E
    . Analysis of the physician variable in pain management. Pain Med 2001;2:317–27.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Wolfert MZ,
    2. Gilson AM,
    3. Dahl JL,
    4. Cleary JF
    . Opioid analgesics for pain control: Wisconsin physicians' knowledge, beliefs, attitudes, and prescribing practices. Pain Med 2010;11:425–34.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Clark JD
    . Chronic pain prevalence and analgesic prescribing in a general medical population. J Pain Symptom Manage 2002;23:131–7.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Elder NC,
    2. Simmons T,
    3. Regan S,
    4. Gerrety E
    . Care for patients with chronic nonmalignant pain with and without chronic opioid prescriptions: a report from the Cincinnati Area Research Group (CARinG) Network. J Am Board Fam Med 2012;25:652–60.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Starrels JL,
    2. Becker WC,
    3. Weiner MG,
    4. Li X,
    5. Heo M,
    6. Turner BJ
    . Low use of opioid risk reduction strategies in primary care even for high risk patients with chronic pain. J Gen Intern Med 2011;26:958–64.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. DiPaula BA,
    2. Menachery E
    . Physician-pharmacist collaborative care model for buprenorphine-maintained opioid-dependent patients. J Am Pharm Assoc 2015;55:187–92.
    OpenUrl
  16. 16.↵
    1. Ma JD,
    2. Tran V,
    3. Chan C,
    4. Mitchell WM,
    5. Atayee RS
    . Retrospective analysis of pharmacist interventions in an ambulatory palliative care practice. J Oncol Pharm Pract 2016;22:757–76.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Richardson TE,
    2. O'Reilly CL,
    3. Chen TF
    . A comprehensive review of the impact of clinical pharmacy services on patient outcomes in mental health. Int J Clin Pharm 2014;36:222–32.
    OpenUrlPubMed
  18. 18.↵
    1. Bultman DC,
    2. Svarstad BL
    . Effects of pharmacist monitoring on patient satisfaction with antidepressant medication therapy. J Am Pharm Assoc 2002;42:36–43.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Bungay KM,
    2. Adler DA,
    3. Rogers WH,
    4. et al
    . Description of a clinical pharmacist intervention administered to primary care patients with depression. Gen Hosp Psychiatry 2004;26:210–8.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Doherty RB,
    2. Crowley RA
    . Principles supporting dynamic clinical care teams: an American College of Physicians position paper. Ann Intern Med 2013;159:620–6.
    OpenUrlCrossRefPubMedWeb of Science
  21. 21.↵
    1. Giberson S,
    2. Yoder S,
    3. Lee MP
    . Improving patient and health system outcomes through advanced pharmacy practice. A report to the U.S. Surgeon General. Office of the Chief Pharmacist. U.S. Public Health Service, December 2011. Available from https://dcp.psc.gov/OSG/pharmacy/sc_comms_sg_report.aspx. Accessed November 13, 2017.
  22. 22.↵
    1. Valgus J,
    2. Jarr S,
    3. Schwartz R,
    4. Rice M,
    5. Bernard SA
    . Pharmacist-led, interdisciplinary model for delivery of supportive care in the ambulatory cancer clinic setting. J Oncol Pract 2010;6:e1–4.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Wilson S,
    2. Wahler R,
    3. Brown J,
    4. Doloresco F,
    5. Monte SV
    . Impact of pharmacist intervention on clinical outcomes in the palliative care setting. Am J Hosp Palliat Care 2011;28:316–20.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Thompson CA
    . Pharmacist, physician collaborate at clinic to treat opioid dependence. Am J Health Syst Pharm 2016;73:738–9.
    OpenUrlFREE Full Text
  25. 25.↵
    1. Elder N,
    2. Penm M,
    3. Pallerla H,
    4. et al
    . Provision of Recommended Chronic Pain Assessment and Management in Primary Care: Does Patient-Centered Medical Home (PCMH) Recognition Make a difference? J Am Board Fam Med 2016;29:474–81.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

The Journal of the American Board of Family     Medicine: 31 (1)
The Journal of the American Board of Family Medicine
Vol. 31, Issue 1
January-February 2018
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Impact of Pharmacist Previsit Input to Providers on Chronic Opioid Prescribing Safety
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
12 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Impact of Pharmacist Previsit Input to Providers on Chronic Opioid Prescribing Safety
Nicholas Cox, Casey R. Tak, Susan E. Cochella, Eric Leishman, Karen Gunning
The Journal of the American Board of Family Medicine Jan 2018, 31 (1) 105-112; DOI: 10.3122/jabfm.2018.01.170210

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Impact of Pharmacist Previsit Input to Providers on Chronic Opioid Prescribing Safety
Nicholas Cox, Casey R. Tak, Susan E. Cochella, Eric Leishman, Karen Gunning
The Journal of the American Board of Family Medicine Jan 2018, 31 (1) 105-112; DOI: 10.3122/jabfm.2018.01.170210
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Conclusions
    • Appendix
    • Notes
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Designing a primary care pharmacist-led review for people treated with opioids for persistent pain: a multi-method qualitative study
  • Adoption of opioid-prescribing guidelines in primary care: a realist synthesis of contextual factors
  • Strategies supporting sustainable prescribing safety improvement interventions in English primary care: a qualitative study
  • Technology-Enabled and Artificial Intelligence Support for Pre-Visit Planning in Ambulatory Care: Findings From an Environmental Scan
  • Impact of Physician-Pharmacist Collaboration on Diabetes Outcomes and Health Care Use
  • A New Quality Improvement Toolkit to Improve Opioid Prescribing in Primary Care
  • Interventions Must Be Realistic to Be Useful and Completed in Family Medicine
  • Google Scholar

More in this TOC Section

  • Successful Implementation of Integrated Behavioral Health
  • Identifying and Addressing Social Determinants of Health with an Electronic Health Record
  • Integrating Adverse Childhood Experiences and Social Risks Screening in Adult Primary Care
Show more Original Research

Similar Articles

Keywords

  • Benzodiazepines
  • Chronic Pain
  • Drug Monitoring
  • Naloxone
  • Opioid Analgesics
  • Pain Management
  • Pharmacists
  • Pilot Study
  • Prescriptions
  • Primary Health Care
  • Quality Improvement
  • Referral and Consultation

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2025 American Board of Family Medicine

Powered by HighWire